Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: The NIH experience.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 28342916.
- Also identified by DOI 10.1016/j.jaci.2017.02.026 and PMC identifier 5546986.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Granulocyte transfusions are a relatively safe adjunctive therapeutic option for patients with chronic granulomatous disease and severe/refractory bacterial or fungal infections. Early initiation, high frequency and sustained therapy is associated with significantly better outcomes.
Medical subject headings
- Granulocytes
- Granulomatous Disease, Chronic
- Infections
- Leukocyte Transfusion